User:107.148.210.70/sandbox

Elabscience
Elabscience is a biotechnology company, specializes in immunodiagnostic technology for life science community. It was founded in 2009 in Wuhan, Hubei, China. Elabscience has complete platform for R&D and manufacture. Its in-house QC for every product can keep customers' experiment results more consistent and precise. Due to the high-quality reagents and professional service, with the development of biotechnology, its customers have spread in more than 100 countries all over the world.

History
In 2009, Elabscience was founded in Wuhan, China. In 2011, ELISA Kits enter domestic market. In 2012, Expand international market. In 2014, Moves into new building In 2015, Passed ISO 9001 Certification. Primary and Flow cytometry antibodies enter market. In 2016, US office established. Biochemical kits enter market. In 2017, Moves into Biolake Valley. In 2018, Cell and related products enter international market In 2019, Was selected as recommended ELISA Kit supplier on CiteAb.

Products and services
Elabscience serves biology research and analytical laboratories markets with its 5 technology platforms. These include: immunology, protein expression, antibody generation, cell biology and molecular biology. Its major products cover Recombinant Proteins, Peptides, FCM Antibodies, Antibodies, ELISA Kits, CLIA Kits, Labeling Kits, Biochemical Kits, GICA Kits, Chromatographic Media, Cell Line, Cell Culture Products and Other Reagents.

Elabscience also provides the lab services including molecular synthesis service (gene synthesis), peptide service, protein service (bacterial and yeast expression) and antibody (polyclonal antibody) service.

Publications with Elabscience products

 * Raparelli V, Basili S, Carnevale R, et al. (2017). Low-Grade Endotoxemia And Platelet Activation In Cirrhosis. Hepatology, 65(2): 571-581. [1]


 * Lê V B, Schneider J G, Boergeling Y, et al. (2015). Platelet Activation And Aggregation Promote Lung Inflammation And Influenza Virus Pathogenesis. American Journal of Respiratory & Critical Care Medicine, 191(7): 804-819. [2]


 * Yamada D, Rizvi S, Razumilava N, et al. (2015). Il-33 Facilitates Oncogene-Induced Cholangiocarcinoma In Mice By An Interleukin-6-Sensitive Mechanism. Hepatology, 61(5): 1627-1642. [3]


 * Delalat B, Cozzi C, Rasi Ghaemi S, et al. (2018). Microengineered Bioartificial Liver Chip for Drug Toxicity Screening. Advanced Functional Materials, 1801825. [4]